Postmortem digoxin-like immunoreactive substances (DLIS) in patients not treated with digoxin

Human and Experimental Toxicology

Volumn 18, Issue 2, 1999, Pages 67-70

  Bentur, Yedidia ^a   Tsipiniuk, Alla ^a   Taitelman, Uri ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Digoxin; Digoxin like immunoreactive substances; Postmortem

Indexed keywords

DIGITALIS LIKE FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOPSY; BLOOD SAMPLING; CLINICAL ARTICLE; FEMALE; FEMORAL ARTERY; HUMAN; IMMUNOASSAY; INTENSIVE CARE; MALE; PRIORITY JOURNAL; TIME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AUTOPSY; DIGOXIN; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0032984590     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/096032799678839761     Document Type: Article

References (18)

1. Karboski JA et al. Marked digoxin-like immunoreactive factor interference with an enzyme immunoassay. Drug Intelligence and Clinical Pharmacy 1988; 22: 703-705.
2. Morris RG et al. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods. European Journal of Clinical Pharmacology 1990; 39: 359-363.
3. Stone J et al. Effect of endogenous digoxin-like substances on the interpretation of high concentrations of digoxin in children. Journal of Pediatrics 1990: 117: 321-325.
4. Goto A et al. Digoxin-like immunoreactivity: is it still worth measuring? Life Sciences 1991; 49: 1667-1678.
5. Yang S-S, Korula J, Sundheimer JE, Keyser AJ. Digoxin-like immunoreactive substances in chronic liver disease. Hepatology 1989; 9: 363-366.
6. Howarth DM, Sampson DC, Hawker FH, Young A. Digoxin-like immunoreactive substances in the plasma of intensive care unit patients: relationship to organ dysfunction. Anaesthesia and Intensive Care 1990; 18: 45-52.
7. Graves SW, Brown B, Valdes Jr R. An endogenous digoxin-like substance in patients with renal impairment. Annals of Internal Medicine 1983; 99: 604-608.
8. Poston L, Morris JF, Wolfe CD, Hilton PJ. Serum digoxin-like substances in pregnancy-induced hypertension. Clinical Science 1989; 77: 189-194.
9. Kerkez SA et al. A longitudinal study of maternal digoxin-like immunoreactive substances in normotensive pregnancy and pregnancy-induced hypertension. American Journal of Obstetrics and Gynecology 1990; 162: 783-787.
10. Koren G et al. Endogenous digoxin-like substance(s) associated with uneventful and high-risk pregnancies. Developmental Pharmacology and Therapeutics 1988; 11: 82-87.
11. Versano S et al. Endogenous digoxin-like immunoreactive factor is elevated in advanced chronic respiratory failure. Chest 1992; 101: 146-149.
12. Koren G, Parker R. Interpretation of excessive serum concentrations of digoxin in children. American Journal of Cardiologv 1985; 55: 1210-1214.
13. Koren G et al. Interpretation of elevated postmortem serum concentrations of digoxin in infants and children. Archives of Pathology and Laboratory Medicine 1989; 113: 758-761.
14. Holt DW, Benstead JG. Postmortem assay of digoxin by radioimmunoassay. Journal of Clinical Pathology 1975; 28: 483-486.
15. Vorpahl TE, Coe JI. Correlation of antemortem and postmortem digoxin levels. Journal of Forensic Sciences 1978; 23: 329-334.
16. O'Sullivan JJ, McCarthy PT, Wren C. Differences in amiodarone, digoxin, flecainide and sotalol concentrations between antemortem serum and femoral postmortem blood, Human & Experimental Toxicology 1995; 14: 605-608.
17. Ritz S, Kaatsch HJ. Interpretation of postmortem digoxin levels: evaluating a 'corrective factor' for postmortem blood digoxin concentration. Zeitschrift für Rechtsmedizin 1990; 103: 573-580.
18. Koren G, MacLeod SM. Postmortem redistribution of digoxin in rats. Journal of Forensic Sciences 1985; 30: 92-96.